(0.32%) 5 116.16 points
(0.30%) 38 356 points
(0.37%) 15 987 points
(-0.95%) $83.05
(5.36%) $2.03
(0.35%) $2 355.30
(0.50%) $27.67
(4.18%) $960.65
(-0.27%) $0.932
(-0.44%) $10.98
(-0.58%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 36 779.00 |
平均出来高 | 219 696 |
時価総額 | 43.02M |
EPS | $-0.0700 ( 2024-03-21 ) |
次の収益日 | ( $-0.0500 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.96 |
ATR14 | $0.00300 (0.20%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-17 | Strobeck Mark | Sell | 6 101 | Common Stock |
2024-03-17 | Timmins Megan C. | Sell | 3 137 | Common Stock |
2024-03-14 | Neri Jesse | Buy | 47 190 | Stock Option (Right to Buy) |
2024-03-14 | Neri Jesse | Buy | 33 330 | Common Stock |
2024-03-14 | Strobeck Mark | Buy | 100 000 | Common Stock |
INSIDER POWER |
---|
98.03 |
Last 94 transactions |
Buy: 5 892 041 | Sell: 1 731 308 |
ボリューム 相関
Rockwell Medical Inc 相関
10 最も正の相関 | |
---|---|
GETVV | 0.949 |
SPRB | 0.915 |
TNXP | 0.888 |
PIRS | 0.888 |
JFIN | 0.885 |
THRX | 0.883 |
UBFO | 0.883 |
LIVE | 0.878 |
PSTX | 0.878 |
REKR | 0.87 |
10 最も負の相関 | |
---|---|
VERA | -0.868 |
AHPI | -0.856 |
LAWS | -0.849 |
GRPH | -0.848 |
EA | -0.845 |
AMGN | -0.836 |
TUEM | -0.823 |
LCAP | -0.82 |
NAKD | -0.819 |
PROC | -0.817 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Rockwell Medical Inc 相関 - 通貨/商品
Rockwell Medical Inc 財務諸表
Annual | 2023 |
収益: | $83.61M |
総利益: | $8.70M (10.41 %) |
EPS: | $-0.360 |
FY | 2023 |
収益: | $83.61M |
総利益: | $8.70M (10.41 %) |
EPS: | $-0.360 |
FY | 2022 |
収益: | $72.81M |
総利益: | $4.08M (5.60 %) |
EPS: | $-2.09 |
FY | 2021 |
収益: | $61.93M |
総利益: | $-2.42M (-3.91 %) |
EPS: | $-4.75 |
Financial Reports:
No articles found.
Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。